Although mutations in caspase-10 have been demonstrated in Non-Hodgkin's lymphoma and are thought to contribute to disease pathogenesis [16], such mutations have not been detected in B lineage ALL [17], and are not associated with breast or ovarian cancer risk [44]. This evidence concerns the gene CASP10 and ovarian cancer.